Mitochondrially Targeted Gene Therapy Rescues Visual Loss in a Mouse Model of Leber’s Hereditary Optic Neuropathy is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Eye Institute
Grant: R24 EY028785
National Eye Institute
Grant: R01 EY 027414
National Eye Institute
Grant: R01 EY017141
National Eye Institute
Grant: P30 EY014801
NIH HHS
Grant: R24 EY028785, R01 EY 027414, R01 EY017141, and P30 EY014801
NEI NIH HHS
Grant: P30 EY021721
National Institutes of Health
Grant: 5R01EY017141-05
Modification of AdenoAssociated Virus to deliver DNA directly to Mitochondria
National Institutes of Health
Grant: 5R01EY027414-03
Intravenous MitoTargeted AAV9 Gene Therapy for Treatment of Visual Loss and Encephalopathy in Leigh Syndrome and NARP
National Institutes of Health
Grant: 5P30EY014801-03
Miami Center for Vision Research
National Institutes of Health
Grant: 1R24EY028785-01A1
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations
FWCI
0.18
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals